Atlas Trials

Efficacy and Tolerability of Low-Dose Enzalutamide in Prostate Cancer

Clinical trial NCT06718647 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06718647
Sponsor
Monica Boitano
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Prostate Cancer Metastatic Disease
Start date
2025-09-01
Primary completion
2025-12-31
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.